Panbela Therapeutics, Inc. (PBLA)
OTCMKTS: PBLA · Delayed Price · USD
0.340
0.00 (0.06%)
Jul 19, 2024, 3:36 PM EDT - Market open
Panbela Therapeutics Market Cap
Panbela Therapeutics has a market cap or net worth of $1.65 million as of July 22, 2024. Its market cap has increased by 65.16% in one year.
Market Cap
1.65M
Enterprise Value
5.58M
1-Year Change
65.16%
Ranking
n/a
Category
Stock Price
$0.34
Market Cap Chart
Since January 3, 2017, Panbela Therapeutics's market cap has decreased from $32.50M to $1.65M, a decrease of -94.92%. That is a compound annual growth rate of -33.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2024 | 500.00K | -89.36% |
| Dec 29, 2023 | 4.70M | 104.35% |
| Dec 30, 2022 | 2.30M | -90.13% |
| Dec 31, 2021 | 23.30M | -32.07% |
| Dec 31, 2020 | 34.30M | 23.38% |
| Dec 31, 2019 | 27.80M | 57.06% |
| Dec 31, 2018 | 17.70M | -51.77% |
| Dec 29, 2017 | 36.70M | 12.92% |
| Jan 3, 2017 | 32.50M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |